Hims & Hers Health, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
Kare Schultz, a Director of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
Patrick Harrison Carroll, Chief Medical Officer of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
Andrew Dudum, Chief Executive Officer, a Director and 10% owner of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
Michael Chi, Chief Operating Officer of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc., sold 64,771 shares of common stock on June 18, 2026.
NYSE
Deborah M. Autor, Chief Policy Officer and a Director of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
David B Wells, a Director of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
Mohamed Elshenawy, CTO of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
Irene Becklund, PAO of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
Christopher D Payne, a Director of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
Mohamed Elshenawy, CTO of Hims & Hers Health, Inc., received 1,200,000 shares of common stock on August 12, 2026.
NYSE
Kare Schultz, a Director of Hims & Hers Health, Inc., received 8,223 shares of common stock on August 12, 2026.
NYSE
Garcia Andrea G Perez, a Director of Hims & Hers Health, Inc., received 8,223 shares of common stock on August 12, 2026.
NYSE
Anja Manuel, a Director of Hims & Hers Health, Inc., received 8,223 shares of common stock on August 12, 2026.
NYSE
Patrick Harrison Carroll, Chief Medical Officer of Hims & Hers Health, Inc., received 260 shares of common stock on August 12, 2026.
NYSE
David B Wells, a Director of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 12, 2026.
NYSE
Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc., sold 7,163 shares of common stock on July 17, 2026 for $31.99 per share.
NYSE
Hims & Hers Health, Inc. Chief Financial Officer, Oluyemi Okupe, reported the sale of 7,163 shares of Class A Common Stock for an average price of $36.4863, executed under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Chief Medical Officer Patrick Harrison Carroll acquired 25,926 shares of Hims & Hers Health, Inc. through RSU vesting, with 8,310 shares withheld for taxes.
NYSE
Hims & Hers Health, Inc. CFO Oluyemi Okupe reported the vesting of restricted stock units and subsequent tax-related share withholding.
NYSE
Chief Policy Officer Deborah M. Autor exercised restricted stock units and sold shares to cover tax obligations.
NYSE
Hims & Hers Health, Inc. Chief Operating Officer Michael Chi reported the vesting of restricted stock units and subsequent sale of shares under a Rule 10b5-1 plan.
NYSE
Hims & Hers Health, Inc. PAO Irene Becklund reported the vesting of restricted stock units and subsequent sale of shares under a Rule 10b5-1 plan.
NYSE
Chief Legal Officer Soleil Boughton acquired 42,261 shares via RSU vesting, with 23,315 shares withheld for tax obligations.
NYSE
CEO Andrew Dudum acquired 154,991 shares of Hims & Hers Health, Inc. through RSU vesting, with 85,632 shares withheld for taxes.
NYSE
Mohamed Elshenawy, CTO of Hims & Hers Health, Inc., reported the vesting of RSUs and subsequent sale of shares via a 10b5-1 plan.
NYSE
Director David B. Wells acquired 4,613 shares of Hims & Hers Health, Inc. through the vesting and conversion of restricted stock units.
NYSE
Director Kare Schultz acquired 3,656 shares of Hims & Hers Health, Inc. through the vesting of restricted stock units.
NYSE
Director Andrea G. Perez Garcia acquired 3,656 shares of Hims & Hers Health, Inc. Class A Common Stock through the vesting of restricted stock units.